Ignite Creation Date:
2025-12-24 @ 1:06 PM
Ignite Modification Date:
2025-12-29 @ 5:48 PM
Study NCT ID:
NCT05427461
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-03
First Post:
2022-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2
Sponsor:
Institut Claudius Regaud
Organization:
Study Overview
Official Title:
Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2025-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SAMHY2
Brief Summary:
Pilot, prospective, monocentric study aimed at evaluating the rate of patients with circulating "cancer cell/macrophage" hybrid cells in the peripheral blood and the evolution of this rate over time.
The study will be conducted on a population of patients with leiomyosarcoma and treated in the context of routine care. 20 patients will be included:
* 10 patients with localized disease.
* 10 patients with metastatic disease.
For each included patient, blood samples will be collected during baseline visit and up to 24 months after inclusion.
The study will be conducted on a population of patients with leiomyosarcoma and treated in the context of routine care. 20 patients will be included:
* 10 patients with localized disease.
* 10 patients with metastatic disease.
For each included patient, blood samples will be collected during baseline visit and up to 24 months after inclusion.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: